BiotechTubeBiotechTube
Home/GenSight Biologics/Jan Eryk Umiastowski
JE

Jan Eryk Umiastowski

Chief Financial Officer

GenSight Biologics

Therapeutic Areas

OphthalmologyNeurodegenerative Diseases

GenSight Biologics Pipeline

DrugIndicationPhase
GS010 (lenadogene nolparvovec)Leber Hereditary Optic Neuropathy (LHON) due to ND4 mutationPhase 3
GS030Retinitis Pigmentosa (RP)Phase 1/2
Preclinical ProgramsGeographic Atrophy in Dry Age-Related Macular Degeneration (Dry-AMD)Preclinical

Leadership Team at GenSight Biologics

LR
Laurence Rodriguez
Chief Executive Officer
DM
Dr. Magali Taiel
Chief Medical Officer
DS
Dr. Scott Jeffers
Chief Technical Officer
JS
José-Alain Sahel
Scientific Co-Founder
BR
Botond Roska
Scientific Co-Founder
DN
Dr. Nancy J. Newman
Presenter (Emory University) - Key Opinion Leader associated with trial data
View full GenSight Biologics profile